Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV003480498 | SCV004226909 | likely pathogenic | not provided | 2023-06-07 | criteria provided, single submitter | clinical testing | PM2, PVS1 |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003480498 | SCV005623363 | pathogenic | not provided | 2024-10-28 | criteria provided, single submitter | clinical testing | The FLCN c.1150_1160del (p.Val384Phefs*2) variant alters the translational reading frame of the FLCN mRNA and causes the premature termination of FLCN protein synthesis. This variant has been reported in the published literature in an individual with Birt-Hogg-Dube (BHD) syndrome (PMID: 35477461 (2022)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as pathogenic. |